Eurobio Scientific

CNR validation of two COVID-19 serology tests - Seite 2

 

Serological tests for the detection of anti-SARS CoV-2 antibodies

• SNIBE range automated CLIA test (Maglumi equipment)
• Wantaï range ELISA Test (generic equipment in ELISA microplate format)
• NG Biotech rapid test (single use test)

Eurobio Scientific has so far received orders from 80 laboratories for the three serology ranges and is continuing to market PCR tests.

Covid-19 sales

As of May 31, 2020, the company recorded cumulative sales of more than 26 million euros, solely on products related to Covid-19, with a gross margin progressing compared to its average value in 2019. These products include the different types of tests as well as sales of the corresponding equipment.

For Jean-Michel CARLE, President and CEO of Eurobio Scientific, "With the launches of our CNR-validated molecular biology and serology offers, our objective is to provide our customers with the widest and most complementary range to allow the best choice depending on epidemic situations. I would like to thank here our partners who have made every effort to make these tests available without delay in order to meet demand. Thank you also to our team who remained very mobilized, in particular to ensure the production of our proprietary test and the logistics of taking orders and supplying our customers on time.”

Next financial meeting
Eurobio Scientific 2020 annual shareholders meeting: June 23, 2020

Exceptionally, due to the Covid-19 epidemic, participation in this meeting will be in the form of remote proxies or votes.

About Eurobio Scientific Eurobio Scientific (ex Diaxonhit) is a key player in the field of specialty in vitro diagnostics. It is involved from research to manufacturing and commercialization of diagnostic tests in the fields of transplantation, immunology and infectious diseases, and sells instruments and products for research laboratories, including biotechnology and pharmaceutical companies. Through many partnerships and a strong presence in hospitals, Eurobio Scientific has established its own distribution network and a portfolio of proprietary products in the molecular biology field. The Group has approximately 120 employees and two production units based in the Paris region and in the United States, and an affiliate based in Dorking UK.